Reviva Pharmaceuticals Holdings, Inc. , a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases.
Reviva Pharmaceuticals Holdings stock last closed at $0.88, up 0.8% from the previous day, and has decreased 69.76% in one year. It has overperformed other stocks in the Biotechnology industry by 0.08 percentage points. Reviva Pharmaceuticals Holdings stock is currently +80.82% from its 52-week low of $0.49, and -79.51% from its 52-week high of $4.28.
There are currently 46.74M RVPH shares outstanding. The market value of RVPH is $40.99M. In the last 24 hours, 278,131 RVPH shares were traded.
You will need a brokerage account in order to access the NASDAQ market and buy RVPH stock.
Based on our research, eToro is the best place to buy stocks. Here's why:
Get $10 towards your share purchase by creating an account with eToro today. This offer is only for US users.
Open eToro AccountNow that you've selected your brokerage, you need to fill out some personal info so you are able to invest in RVPH stock today.
Now that you've created your account on the best investment app, you need to deposit funds:
Check out the walkthrough below if you need help depositing funds into your investment account.
Once you have selected the best place to buy Reviva Pharmaceuticals Holdings stock, it's important to evaluate their stock prior to buying, so you can understand the risk and upside.
WallStreetZen was designed to help part-time investors do more accurate fundamental analysis.
You can view all of the due diligence checks on RVPH's stock page.
Investors use a variety of different financial metrics, analyses, models, and charts to gauge RVPH's true value.
Using relative valuations methods:
You can access additional valuation analysis on RVPH's stock here.
Out of 4 Wall Street analysts who monitor RVPH, the consensus analyst rating on Reviva Pharmaceuticals Holdings is a Strong Buy
Please keep in mind that analyst ratings are not recommendations, nor are they financial advice.
You can dig deeper into what analysts are saying on the Reviva Pharmaceuticals Holdings stock forecast page.
In the past 12 months, insiders at RVPH have not bought or sold any shares.
Dig into more about who owns RVPH shares here.
No, Reviva Pharmaceuticals Holdings doesn't provide an income stream by paying out dividends.
One of the primary reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to see what other investors have to say.
There are two primary options:
Click the Open Trade button and eToro will execute your order.
If you want more assistance investing in stocks on eToro, watch the how to video below:
Now that you own some RVPH stock, you'll want to keep up with your company.
Add RVPH to a watchlist to track your RVPH stock.
To reiterate, here are the 6 steps for buying Reviva Pharmaceuticals Holdings stock:
If you are looking for a brokerage account, eToro is our favorite option.
Get Started with eToro TodayIf you would like to track your investment in Reviva Pharmaceuticals Holdings, click the button below.